In patients with type 1 diabetes, conventional multiple daily injections and self-monitoring of blood glucose can improve hypoglycemia awareness and prevent ongoing severe hypoglycemia without compromising overall metabolic control, according to data from the HypoCompass study.
In a 24-week multicenter study at five UK diabetes referral centers, researchers evaluated 96 patients (ages 18 to 74 years) with c-peptide-negative type 1 diabetes. The mean duration of diabetes among the patients was 29 years. All participants were determined to have impaired awareness of hypoglycemia (IAH) based on a Gold score ≥4.
Full Story »
Personalize your page!
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.